Cargando…
Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
Pantothenic acid (vitamin B5) is an essential trace nutrient required for the synthesis of coenzyme A (CoA). It has previously been shown that pantothenic acid is significantly decreased in multiple brain regions in both Alzheimer’s disease (ADD) and Huntington’s disease (HD). The current investigat...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468190/ https://www.ncbi.nlm.nih.gov/pubmed/34564384 http://dx.doi.org/10.3390/metabo11090569 |
_version_ | 1784573600849723392 |
---|---|
author | Scholefield, Melissa Church, Stephanie J. Xu, Jingshu Patassini, Stefano Hooper, Nigel M. Unwin, Richard D. Cooper, Garth J. S. |
author_facet | Scholefield, Melissa Church, Stephanie J. Xu, Jingshu Patassini, Stefano Hooper, Nigel M. Unwin, Richard D. Cooper, Garth J. S. |
author_sort | Scholefield, Melissa |
collection | PubMed |
description | Pantothenic acid (vitamin B5) is an essential trace nutrient required for the synthesis of coenzyme A (CoA). It has previously been shown that pantothenic acid is significantly decreased in multiple brain regions in both Alzheimer’s disease (ADD) and Huntington’s disease (HD). The current investigation aimed to determine whether similar changes are also present in cases of Parkinson’s disease dementia (PDD), another age-related neurodegenerative condition, and whether such perturbations might occur in similar regions in these apparently different diseases. Brain tissue was obtained from nine confirmed cases of PDD and nine controls with a post-mortem delay of 26 h or less. Tissues were acquired from nine regions that show high, moderate, or low levels of neurodegeneration in PDD: the cerebellum, motor cortex, primary visual cortex, hippocampus, substantia nigra, middle temporal gyrus, medulla oblongata, cingulate gyrus, and pons. A targeted ultra–high performance liquid chromatography—tandem mass spectrometry (UHPLC-MS/MS) approach was used to quantify pantothenic acid in these tissues. Pantothenic acid was significantly decreased in the cerebellum (p = 0.008), substantia nigra (p = 0.02), and medulla (p = 0.008) of PDD cases. These findings mirror the significant decreases in the cerebellum of both ADD and HD cases, as well as the substantia nigra, putamen, middle frontal gyrus, and entorhinal cortex of HD cases, and motor cortex, primary visual cortex, hippocampus, middle temporal gyrus, cingulate gyrus, and entorhinal cortex of ADD cases. Taken together, these observations indicate a common but regionally selective disruption of pantothenic acid levels across PDD, ADD, and HD. |
format | Online Article Text |
id | pubmed-8468190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84681902021-09-27 Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia Scholefield, Melissa Church, Stephanie J. Xu, Jingshu Patassini, Stefano Hooper, Nigel M. Unwin, Richard D. Cooper, Garth J. S. Metabolites Article Pantothenic acid (vitamin B5) is an essential trace nutrient required for the synthesis of coenzyme A (CoA). It has previously been shown that pantothenic acid is significantly decreased in multiple brain regions in both Alzheimer’s disease (ADD) and Huntington’s disease (HD). The current investigation aimed to determine whether similar changes are also present in cases of Parkinson’s disease dementia (PDD), another age-related neurodegenerative condition, and whether such perturbations might occur in similar regions in these apparently different diseases. Brain tissue was obtained from nine confirmed cases of PDD and nine controls with a post-mortem delay of 26 h or less. Tissues were acquired from nine regions that show high, moderate, or low levels of neurodegeneration in PDD: the cerebellum, motor cortex, primary visual cortex, hippocampus, substantia nigra, middle temporal gyrus, medulla oblongata, cingulate gyrus, and pons. A targeted ultra–high performance liquid chromatography—tandem mass spectrometry (UHPLC-MS/MS) approach was used to quantify pantothenic acid in these tissues. Pantothenic acid was significantly decreased in the cerebellum (p = 0.008), substantia nigra (p = 0.02), and medulla (p = 0.008) of PDD cases. These findings mirror the significant decreases in the cerebellum of both ADD and HD cases, as well as the substantia nigra, putamen, middle frontal gyrus, and entorhinal cortex of HD cases, and motor cortex, primary visual cortex, hippocampus, middle temporal gyrus, cingulate gyrus, and entorhinal cortex of ADD cases. Taken together, these observations indicate a common but regionally selective disruption of pantothenic acid levels across PDD, ADD, and HD. MDPI 2021-08-25 /pmc/articles/PMC8468190/ /pubmed/34564384 http://dx.doi.org/10.3390/metabo11090569 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Scholefield, Melissa Church, Stephanie J. Xu, Jingshu Patassini, Stefano Hooper, Nigel M. Unwin, Richard D. Cooper, Garth J. S. Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title | Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title_full | Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title_fullStr | Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title_full_unstemmed | Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title_short | Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title_sort | substantively lowered levels of pantothenic acid (vitamin b5) in several regions of the human brain in parkinson’s disease dementia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468190/ https://www.ncbi.nlm.nih.gov/pubmed/34564384 http://dx.doi.org/10.3390/metabo11090569 |
work_keys_str_mv | AT scholefieldmelissa substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT churchstephaniej substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT xujingshu substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT patassinistefano substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT hoopernigelm substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT unwinrichardd substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT coopergarthjs substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia |